Conference Proceedings
Long-Term Safety And Efficacy Of Add-On Cannabidiol (CBD) Treatment In Patients With Dravet Syndrome In An Open-Label Extension Trial (GWPCARE5)
R Nabbout, J Halford, IE Scheffer, R Sanchez-Carpintero, Y Shiloh Malawsky, M Wong, D Checketts, K VanLandingham
EPILEPSIA | WILEY | Published : 2019
Grants
Funding Acknowledgements
GW Research Ltd, Cambridge, UK.